Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Deborah Thomas

Initial Experience With CMC-544 (Inotuzumab Ozogamicin) in Pediatric Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia

Pediatric Blood and Cancer

English

Role of Tyrosine Kinase Inhibitors in the Management of Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia

Current Hematologic Malignancy Reports

English

Splenectomy in Patients With Myeloproliferative Neoplasms: Efficacy, Complications and Impact on Survival and Transformation

Leukemia and Lymphoma

English

The Effect of Peritransplant Minimal Residual Disease in Adults With Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Lymphoma, Myeloma and Leukemia

English

Feasibility of Allografting in Patients With Advanced Acute Lymphoblastic Leukemia After Salvage Therapy With Inotuzumab Ozogamicin

Clinical Lymphoma, Myeloma and Leukemia

English

Four Facets of Classroom Assessments: Obstacles, Obligations, Outcomes, and Opportunities

Action in Teacher Education

Education

2014

English

Unequal Access to Maternal and Neonatal Health in Indonesia With Gender Perspective

2019

English

Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab as Initial Therapy for Chronic Lymphocytic Leukemia

Journal of Clinical Oncology

English

Result of High-Dose Imatinib Mesylate in Patients With Philadelphia Chromosome--Positive Chronic Myeloid Leukemia After Failure of Interferon-

English

Secondary Myelodysplastic Syndrome in a Patient With Philadelphia-Positive Acute Lymphoblastic Leukemia After Achieving a Major Molecular Response With hyperCVAD Plus Imatinib Mesylate

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Deborah Thomas

Initial Experience With CMC-544 (Inotuzumab Ozogamicin) in Pediatric Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia

Role of Tyrosine Kinase Inhibitors in the Management of Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia

Splenectomy in Patients With Myeloproliferative Neoplasms: Efficacy, Complications and Impact on Survival and Transformation

The Effect of Peritransplant Minimal Residual Disease in Adults With Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Feasibility of Allografting in Patients With Advanced Acute Lymphoblastic Leukemia After Salvage Therapy With Inotuzumab Ozogamicin

Four Facets of Classroom Assessments: Obstacles, Obligations, Outcomes, and Opportunities

Unequal Access to Maternal and Neonatal Health in Indonesia With Gender Perspective

Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab as Initial Therapy for Chronic Lymphocytic Leukemia

Result of High-Dose Imatinib Mesylate in Patients With Philadelphia Chromosome--Positive Chronic Myeloid Leukemia After Failure of Interferon-

Secondary Myelodysplastic Syndrome in a Patient With Philadelphia-Positive Acute Lymphoblastic Leukemia After Achieving a Major Molecular Response With hyperCVAD Plus Imatinib Mesylate